Patterson Companies Inc (PDCO) Return on Investment ROI from the third quarter of 2025 to third quarter of 2024 and for the year 2025, average high and low, overall ranking from Jan 25 2025 to Jan 27 2024 - CSIMarket
CSIMarket
 


Patterson Companies Inc   (NASDAQ: PDCO)


Patterson Companies Inc's ROI from its third quarter of 2025 to the third quarter of 2024 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Patterson Companies Inc's ROI in the third quarter of 2025?
Patterson Companies Inc achieved a return on average invested assets (ROI) of 9.51 % in its third quarter of 2025, this is above PDCO's average return on investment of 7.81%.
Patterson Companies Inc invested over the 12 months ending in its third quarter of 2025 $1,456 million

ROI fell compared to the second quarter of 2025, despite the net income growth of 16.76% from the second quarter of 2025.

Within the Healthcare sector 105 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2025 from 676 to 956.

Definition and Formula of Return on Investment



Return On Investment (Jan 25 2025)
III. Quarter
(Oct 26 2024)
II. Quarter
(Jul 27 2024)
I. Quarter
(Apr 27 2024)
IV. Quarter
(Jan 27 2024)
III. Quarter
Y / Y Investment Change TTM -16.04 % -15.67 % -12.27 % -7.31 % 1.94 %
Y / Y Net Income Change TTM -28.42 % -22.44 % 5.14 % 44.16 % 259.2 %
Investment (TTM) in Millions 1,429 1,407 1,423 1,565 1,576
Return On Investment (TTM) 9.51 % 10.37 % 10.78 % 11.36 % 11.15 %
PDCO's Overall Ranking # 956 # 676 # 707 # 0 # 704
Seq. Investment Change TTM -2.46 % -4.18 % -4.61 % -5.83 % -2.03 %
Seq. Net Income Change TTM -10.6 % -7.83 % -9.43 % -4.08 % -3.13 %
Net Income (TTM) in Millions 138 155 168 186 193




Return On Investment PDCO's Ranking
Within: No.
Industry # 32
Sector # 106
Overall # 956

Return On Investment Statistics
High Average Low
14.07 %
7.81 %
-29.55 %
(April 29. 2008)   (Jul 25 2020)







Financial Statements
Patterson Companies Inc's III. Quarter Investments $ 1,429 Millions PDCO's Balance sheet
Patterson Companies Inc's III. Quarter Income $ 31 Millions Quarterly PDCO's Income Statement
PDCO's Income by Division See PDCO's Income by Division


PDCO Annual Return On Investment (Apr 27 2024)
2024
(Apr 29 2023)
2023
(Apr 30 2022)
2022
(Apr 24 2021)
2021
(Apr 25 2020)
2020
Total Investments in Millions 1,565 1,795 1,727 1,663 1,643
Y / Y Investment Growth -12.82 % 3.93 % 3.82 % 1.25 % -31.46 %
Net Income in Millions 186 207 202 155 -589
Y / Y Net Income Growth -10.2 % 2.42 % 30.05 % - -
Annual Return On Investment 11.86 % 11.51 % 11.68 % 9.33 % -35.88 %


Annual Roi Comment
Despite deterioration in net income, company improved ROI to in the fiscal year 2024, company improved ROI to 11.86 % compare to previous year.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PDCO's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PDCO's Competitors
Subscribers only: Roi for Patterson Companies Inc's Suppliers
Subscribers only: Return On Investment for PDCO's Customers

Other Ratios
PDCO's Roa PDCO's Inventory Turnover Ratio PDCO's Growth Rates PDCO's Dividend Statistics
PDCO's Profitability Ratios PDCO's Asset Turnover Ratio PDCO's Dividend Growth
PDCO's Roe PDCO's Valuation Ratios PDCO's Financial Strength Ratios PDCO's Dividend Payout Ratio



Companies with similar Return On Investment at Jan 25 2025, within Healthcare Sector ROI
Catalyst Pharmaceuticals Inc   25.42 %
Inmode Ltd   25.32 %
Engene Therapeutics Inc   24.80 %
Halozyme Therapeutics Inc   23.75 %
Eli Lilly And Company  23.21 %
Iradimed Corporation  22.70 %
Indivior Pharmaceuticals Inc   22.40 %
Rigel Pharmaceuticals Inc  22.12 %
Corcept Therapeutics Inc  22.09 %
Alkermes Plc   22.09 %
Merck and Co Inc   21.78 %
Mimedx Group Inc   21.42 %
Abbott Laboratories  21.06 %
Curevac N v   20.52 %
Zoetis Inc   20.35 %
Nutriband Inc   19.99 %
Lantheus Holdings Inc   19.91 %
Resmed Inc   19.66 %
United Therapeutics Corporation  19.59 %
Harmony Biosciences Holdings inc   19.43 %
Chemed Corporation  19.41 %
Lifevantage Corp  19.04 %
Kewaunee Scientific Corporation  17.76 %
Insulet Corporation  17.31 %
Genmab A  17.21 %
Pro dex Inc   16.52 %
Third Harmonic Bio Inc   16.37 %
West Pharmaceutical Services Inc   16.34 %
Agilent Technologies inc   16.18 %
Scienture Holdings Inc   16.09 %


Date modified: 2026-09-08T15:11:26+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.